Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Chemical Communications (Cambridge, England)|November 21, 2015
Phosphonium-containing diblock copolymers from living anionic polymerization of 4-diphenylphosphino styreneAlison R Schultz, Gregory B Fahs, Chainika Jangu, et al.Journal of Histotechnology|May 25, 2023
Exosomal miR-192-5p secreted by bone marrow mesenchymal stem cells inhibits hepatic stellate cell activation and targets PPP2R3AJie Tan, Mingtao Chen, Meng Liu, et al.Journal of Oncology|October 20, 2022
Unveiling the Noncanonical Autophagy-Independent Role of ATG7 and ATG9B in Head and Neck Squamous Cell Carcinoma (HNSCC)Yibo Guo, Yiting Sun, Mingtao Chen, et al.Frontiers in Microbiology|February 26, 2021
Synergistic Combination of Linezolid and Fosfomycin Closing Each Other's Mutant Selection Window to Prevent Enterococcal ResistanceLifang Jiang, Na Xie, Mingtao Chen, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|March 18, 2026
Deregulated miR-487b-3p in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin ResistanceMingtao Chen, Jie Tan, Min Huang, et al.Journal of Medical Internet Research|March 4, 2026
Implementation of Reference Framework for Preventive Care for Older Adults: Cross-sectional Qualitative StudyClaire Chenwen Zhong, Mingtao Chen, Chung Yi Lo, et al.Cell Metabolism|February 28, 2026
Neuroimmunometabolic co-evolution in the tumor micro- and macroenvironmentYu Zhang, Weijie Zhuang, Haodong Zhu, et al.Infection and Drug Resistance|December 9, 2021
Development and Validation of an HPLC-UV Method for Quantitation of Linezolid: Application to Resistance Study Using in vitro PK/PD ModelGuang Yang, Yisong Yan, Jun Mao, et al.Vaccine|July 30, 2025
Factors associated with willingness among adults to receive pneumococcal vaccine in Hong Kong: a cross-sectional study using HBM constructsClaire Chenwen Zhong, Zehuan Yang, Mingtao Chen, et al.Oral Diseases|September 17, 2024
CAF-secreted COL5A2 activates the PI3K/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinomaYibo Guo, Mingtao Chen, Jie Yang, et al.Pageof 6